We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Coca Cola Femsa S.A.B. de C.V. (KOF) - free report >>
China Telecom Corp Ltd (CHA) - free report >>
Adicet Bio, Inc. (ACET) - free report >>
Consolidated Communications Holdings, Inc. (CNSL) - free report >>
Image: Bigstock
New Strong Sell Stocks for April 4th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
China Telecom Corporation Limited (CHA - Free Report) is a provider of wireline and mobile telecommunications services. The Zacks Consensus Estimate for its current year earnings has been revised 4.3% downward over the last 30 days.
Coca-Cola FEMSA, S.A.B. de C.V. (KOF - Free Report) is a franchiser and distributor of Coca-Cola trademark beverages. The Zacks Consensus Estimate for its current year earnings has been revised 4.2% downward over the last 30 days.
Consolidated Communications Holdings, Inc. (CNSL - Free Report) is a provider of integrated communications services. The Zacks Consensus Estimate for its current year earnings has been revised 80.6% downward over the last 60 days.
Eagle Bancorp Montana, Inc. (EBMT - Free Report) is a provider of retail banking products and services. The Zacks Consensus Estimate for its current year earnings has been revised 9.8% downward over the last 60 days.
Aceto Corporation (ACET - Free Report) is a seller and distributor of finished dosage form generics and other pharmaceutical products. The Zacks Consensus Estimate for its current year earnings has been revised 4.7% downward over the last 60 days.
View the entire Zacks Rank #5 List.